A simple identification of novel carbonyl reducing enzymes in the metabolism of the tobacco specific carcinogen NNK

Drug Metabolism Letters

Volumn 6, Issue 3, 2012, Pages 174-181

  Skarydova, Lucie ^a   Zverinova, Michaela ^a   Stambergova, Hana ^a   Wsol, Vladimir ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Activity; Carbonyl; Enzymes; HPLC UV; NNAL; NNK; Reducing; SDR

Indexed keywords

CARBONYL DERIVATIVE; CARBONYL REDUCING ENZYME; CARCINOGEN; MICROSOME ENZYME; NNK; RECOMBINANT ENZYME; UNCLASSIFIED DRUG;

ARTICLE; BIOTRANSFORMATION; CARCINOGENICITY; CHEMICAL STRUCTURE; DETOXIFICATION; ENANTIOMER; ENZYME KINETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLITE; PRIORITY JOURNAL; TOBACCO;

ALCOHOL OXIDOREDUCTASES; CARCINOGENS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MICROSOMES, LIVER; NITROSAMINES; PYRIDINES; SMOKING; STEREOISOMERISM;

NICOTIANA TABACUM;

EID: 84876743972     PISSN: 18723128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1872312811206030004     Document Type: Article

References (24)

1. Maertens, L.A.; Upadhyaya, P.; Hecht, S.S.; Zimmerman, C.L. Formation and distribution of NNK metabolites in an isolated perfused rat lung. Drug Metab. Dispos., 2010, 38(5), 752-60.
2. Wang, C.; Dai, Y.; Feng, G.; He, R.; Yang, W.; Li, D.; Zhou, X.; Zhu, L.; Tan, L. Addition of porphyrins to cigarette filters to reduce the levels of benzo[a]pyrene (B[a]P) and tobacco-specific N-nitrosamines (TSNAs) in mainstream cigarette smoke. J. Agric. Food Chem., 2011, 59(13), 7172-7.
3. Stepanov, I.; Upadhyaya, P.; Carmella, S.G.; Feuer, R.; Jensen, J.; Hatsukami, D.K.; Hecht, S.S. Extensive metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers. Cancer Epidemiol. Biomarkers Prev., 2008, 17(7), 1764-73.
4. Maser, E.; Stinner, B.; Atalla, A. Carbonyl reduction of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by cytosolic enzymes in human liver and lung. Cancer Lett., 2000, 148(2), 135-44.
5. Trushin, N.; Leder, G.; El-Bayoumy, K.; Hoffmann, D.; Beger, H.G.; Henne-Bruns, D.; Ramadani, M.; Prokopczyk, B. The tobacco carcinogen NNK is stereoselectively reduced by human pancreatic microsomes and cytosols. Langenbecks Arch. Surg., 2008, 393(4), 571-9.
6. Atalla, A.; Maser, E. Characterization of enzymes participating in carbonyl reduction of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human placenta. Chem. Biol. Interact., 2001, 130-132(1-3), 737-48.
7. Prokopczyk, B.; Trushin, N.; Leszczynska, J.; Waggoner, S.E.; El-Bayoumy, K. Human cervical tissue metabolizes the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, via alpha-hydroxylation and carbonyl reduction pathways. Carcinogenesis, 2001, 22(1), 107-14.
8. Atalla, A.; Breyer-Pfaff, U.; Maser, E. Purification and characterization of oxidoreductases-catalyzing carbonyl reduction of the tobacco-specific nitrosamine 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human liver cytosol. Xenobiotica, 2000, 30(8), 755-69.
9. Breyer-Pfaff, U.; Martin, H.J.; Ernst, M.; Maser, E. Enantioselectivity of carbonyl reduction of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone by tissue fractions from human and rat and by enzymes isolated from human liver. Drug Metab Dispos., 2004, 32(9), 915-22.
10. Kallberg, Y.; Oppermann, U.; Persson, B. Classification of the short-chain dehydrogenase/reductase superfamily using hidden Markov models. FEBS J., 2010, 277(10), 2375-86.
11. Bray, J.E.; Marsden, B.D.; Oppermann, U. The human short-chain dehydrogenase/reductase (SDR) superfamily: a bioinformatics summary. Chem. Biol. Interact., 2009, 178(1-3), 99-109.
12. Carmella, S.G.; Han, S.; Villalta, P.W.; Hecht, S.S. Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in smokers' blood. Cancer Epidemiol. Biomarkers Prev., 2005, 14(11 Pt 1), 2669-72.
13. Church, T.R.; Anderson, K.E.; Le, C.; Zhang, Y.; Kampa, D.M.; Benoit, A.R.; Yoder, A.R.; Carmella, S.G.; Hecht, S.S. Temporal stability of urinary and plasma biomarkers of tobacco smoke exposure among cigarette smokers. Biomarkers, 2010, 15(4), 345-52.
14. Kavvadias, D.; Scherer, G.; Urban, M.; Cheung, F.; Errington, G.; Shepperd, J.; McEwan, M. Simultaneous determination of four tobacco-specific N-nitrosamines (TSNA) in human urine. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2009, 877(11-12), 1185-92.
15. Carmella, S.G.; Hecht, S.S. High-performance liquid chromatographic analysis of metabolites of the nicotine-derived nitrosamines, N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Anal. Biochem., 1985, 145(2), 239-44.
16. Maser, E., Richter, E., Friebertshauser, J. The identification of 11 beta-hydroxysteroid dehydrogenase as carbonyl reductase of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Eur. J. Biochem., 1996, 238(2), 484-9.
17. Gillete JR. Techniques for studiyng drug metabolism in vitro. In: La Du BN, Mandel GH, Way EL, editors. Fundamentals of drug metabolism and drug disposition.Baltimore: The Williams & Wilkins Company; 1971. p. 400-18.
18. Barski, O.A.; Tipparaju, S.M.; Bhatnagar, A. The aldo-keto reductase superfamily and its role in drug metabolism and detoxification. Drug Metab Rev., 2008, 40(4), 553-624.
19. Hoffmann, F.; Maser, E. Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the short-chain dehydrogenase/ reductase superfamily. Drug Metab. Rev., 2007, 39(1), 87-144.
20. Sambrook, J.; MacCallum P. Molecular Cloning: A laboratory manual. Third edition ed.; CSH Press: 2001.
21. Skarydova, L.; Skarka, A.; Novotna, R.; Zivna, L.; Martin, H.J.; Wsol, V.; Maser, E. Partial purification and characterization of a new human membrane-bound carbonyl reductase playing a role in the deactivation of the anticancer drug oracin. Toxicology, 2009, 264(1-2), 52-60.
22. Schrader, E.; Hirsch-Ernst, K.I.; Scholz, E.; Kahl, G.F.; Foth, H. Metabolism of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in primary cultures of rat alveolar type II cells. Drug Metab Dispos., 2000, 28(2), 180-5.
23. Soldan, M.; Nagel, G.; Losekam, M.; Ernst, M.; Maser, E. Interindividual variability in the expression and NNK carbonyl reductase activity of 11beta-hydroxysteroid dehydrogenase 1 in human lung. Cancer Lett., 1999, 145(1-2), 49-56.
24. Finckh, C.; Atalla, A.; Nagel, G.; Stinner, B.; Maser, E. Expression and NNK reducing activities of carbonyl reductase and 11beta-hydroxysteroid dehydrogenase type 1 in human lung. Chem. Biol. Interact., 2001, 130-132(1-3), 761-73.